CY1122094T1 - Φαρμακευτικη συνθεση που περιεχει πολυμερες δεσμευσης φωσφορικων - Google Patents
Φαρμακευτικη συνθεση που περιεχει πολυμερες δεσμευσης φωσφορικωνInfo
- Publication number
- CY1122094T1 CY1122094T1 CY20191101016T CY191101016T CY1122094T1 CY 1122094 T1 CY1122094 T1 CY 1122094T1 CY 20191101016 T CY20191101016 T CY 20191101016T CY 191101016 T CY191101016 T CY 191101016T CY 1122094 T1 CY1122094 T1 CY 1122094T1
- Authority
- CY
- Cyprus
- Prior art keywords
- phosphate binding
- pharmaceutical composition
- composition containing
- containing phosphate
- binding polymers
- Prior art date
Links
- 102000006335 Phosphate-Binding Proteins Human genes 0.000 title abstract 3
- 108010058514 Phosphate-Binding Proteins Proteins 0.000 title abstract 3
- 229920000642 polymer Polymers 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- ZNSIZMQNQCNRBW-UHFFFAOYSA-N sevelamer Chemical compound NCC=C.ClCC1CO1 ZNSIZMQNQCNRBW-UHFFFAOYSA-N 0.000 abstract 1
- 229960003693 sevelamer Drugs 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αφορά ένα δισκίο γρήγορης διάλυσης, το οποίο περιλαμβάνει μια θεραπευτικώς αποτελεσματική ποσότητα ενός πολυμερούς δέσμευσης φωσφορικών, όπως η σεβελαμέρη ή ένα φαρμακευτικώς αποδεκτό άλας ή ένα παράγωγο αυτής, που επιδεικνύει περιορισμένη διόγκωση στη στοματική κοιλότητα, έχει ευχάριστη γεύση και αίσθηση στο στόμα, υψηλή χωρητικότητα δέσμευσης φωσφορικών με κινητική γρήγορης δέσμευσης και απαιτεί λήψη περιορισμένης ποσότητας νερού. Αποκαλύπτεται μια διαδικασία για την παρασκευή αυτού.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2012/002547 WO2013185789A1 (en) | 2012-06-15 | 2012-06-15 | Pharmaceutical composition containing phosphate binding polymer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1122094T1 true CY1122094T1 (el) | 2020-11-25 |
Family
ID=46465179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20191101016T CY1122094T1 (el) | 2012-06-15 | 2019-09-26 | Φαρμακευτικη συνθεση που περιεχει πολυμερες δεσμευσης φωσφορικων |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9849147B2 (el) |
| EP (1) | EP2861236B1 (el) |
| AU (1) | AU2012382602B2 (el) |
| CA (1) | CA2876739C (el) |
| CY (1) | CY1122094T1 (el) |
| DK (1) | DK2861236T3 (el) |
| ES (1) | ES2748578T3 (el) |
| HR (1) | HRP20191669T1 (el) |
| HU (1) | HUE045603T2 (el) |
| LT (1) | LT2861236T (el) |
| PL (1) | PL2861236T3 (el) |
| PT (1) | PT2861236T (el) |
| RS (1) | RS59365B1 (el) |
| SI (1) | SI2861236T1 (el) |
| WO (1) | WO2013185789A1 (el) |
| ZA (1) | ZA201500452B (el) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10245284B2 (en) | 2015-08-19 | 2019-04-02 | Alpex Pharma S.A. | Granular composition for oral administration |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629013A (en) | 1991-04-04 | 1997-05-13 | The Procter & Gamble Company | Chewable calcium carbonate antacid tablet compositions |
| AU699192B2 (en) | 1993-08-13 | 1998-11-26 | Bayer Corporation | Hydrolyzed gelatin as a flavor enhancer in a chewable tablet |
| US6270790B1 (en) | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
| IL164106A0 (en) | 2002-04-04 | 2005-12-18 | Pfizer Prod Inc | Palatable chewable tablet |
| US20080234337A1 (en) * | 2004-08-10 | 2008-09-25 | Ono Pharmaceutical Co., Ltd. | Preventive and/or Remedy for Hyperkalemia Containing Ep4 Agonist |
| US7749536B2 (en) * | 2006-02-14 | 2010-07-06 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture |
| BRPI0717008A2 (pt) | 2006-09-01 | 2014-01-21 | Usv Ltd | Processo para o preparo de cloridrato de sevelamer e formulação do mesmo |
| WO2009034540A1 (en) | 2007-09-11 | 2009-03-19 | Ranbaxy Laboratories Limited | Pharmaceutical composition of sevelamer |
| US8133506B2 (en) * | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
| ES2739888T3 (es) * | 2009-11-30 | 2020-02-04 | Adare Pharmaceuticals Inc | Composiciones y comprimidos farmacéuticos con recubrimiento compresible y métodos de fabricación |
| WO2011135591A2 (en) * | 2010-04-29 | 2011-11-03 | Shasun Pharmaceuticals Limited | Novel tablet composition of polyallylamine polymers |
-
2012
- 2012-06-15 WO PCT/EP2012/002547 patent/WO2013185789A1/en active Application Filing
- 2012-06-15 US US14/408,053 patent/US9849147B2/en active Active
- 2012-06-15 HU HUE12732788A patent/HUE045603T2/hu unknown
- 2012-06-15 AU AU2012382602A patent/AU2012382602B2/en active Active
- 2012-06-15 DK DK12732788.0T patent/DK2861236T3/da active
- 2012-06-15 CA CA2876739A patent/CA2876739C/en active Active
- 2012-06-15 LT LTEP12732788.0T patent/LT2861236T/lt unknown
- 2012-06-15 RS RSP20191300 patent/RS59365B1/sr unknown
- 2012-06-15 SI SI201231657T patent/SI2861236T1/sl unknown
- 2012-06-15 ES ES12732788T patent/ES2748578T3/es active Active
- 2012-06-15 EP EP12732788.0A patent/EP2861236B1/en active Active
- 2012-06-15 PL PL12732788T patent/PL2861236T3/pl unknown
- 2012-06-15 PT PT127327880T patent/PT2861236T/pt unknown
-
2015
- 2015-01-22 ZA ZA2015/00452A patent/ZA201500452B/en unknown
-
2019
- 2019-09-16 HR HRP20191669 patent/HRP20191669T1/hr unknown
- 2019-09-26 CY CY20191101016T patent/CY1122094T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2876739C (en) | 2019-02-26 |
| US9849147B2 (en) | 2017-12-26 |
| US20150182555A1 (en) | 2015-07-02 |
| ES2748578T3 (es) | 2020-03-17 |
| DK2861236T3 (da) | 2019-10-14 |
| PL2861236T3 (pl) | 2020-03-31 |
| ZA201500452B (en) | 2016-10-26 |
| EP2861236B1 (en) | 2019-07-17 |
| LT2861236T (lt) | 2019-09-25 |
| HUE045603T2 (hu) | 2020-01-28 |
| SI2861236T1 (sl) | 2019-10-30 |
| WO2013185789A1 (en) | 2013-12-19 |
| PT2861236T (pt) | 2019-10-28 |
| RS59365B1 (sr) | 2019-11-29 |
| EP2861236A1 (en) | 2015-04-22 |
| HRP20191669T1 (hr) | 2019-12-13 |
| AU2012382602B2 (en) | 2016-02-11 |
| AU2012382602A1 (en) | 2015-01-22 |
| CA2876739A1 (en) | 2013-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202202711B (en) | Sustained-release dosage forms of ruxolitinib | |
| CY1120807T1 (el) | Συνθεσεις και μεθοδοι για την τροποποιηση της smn2 συναρμογης σε ενα υποκειμενο | |
| CY1120334T1 (el) | Υποκατεστημενης 3-αλλογονοαλυλαμινης αναστολεις ssao και χρησεις αυτων | |
| CY1120204T1 (el) | Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο | |
| MX2014015346A (es) | Pirrolo- o pirazolopirimidinas covalentes reversibles utiles para el tratamiento del cancer y de enfermedades autoinmunitarias. | |
| ZA201601534B (en) | Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses | |
| MY178680A (en) | Hydrogel prodrugs | |
| MX2018008061A (es) | Profarmacos de peptido natriuretico tipo c (cnp) con porciones portadoras grandes. | |
| EA201690107A1 (ru) | Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе | |
| WO2013151736A3 (en) | In vivo production of proteins | |
| MX2019003249A (es) | Diagnostico, prevencion y tratamiento de enfermedades de la articulacion. | |
| MX2014004862A (es) | Formulaciones de polimero acrilico. | |
| MX347105B (es) | Composiciones farmaceuticas que comprenden hidromorfona y naloxona. | |
| IN2014DN06966A (el) | ||
| TR201909923T4 (tr) | Böbrek hastalığının önlenmesi ya da tedavisi için pirazol türevini ihtiva eden kompozisyon. | |
| MX340188B (es) | Elaboracion de granulos sin activos y tabletas que comprenden los mismos. | |
| EA032271B9 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
| EA201190312A1 (ru) | Замещенные пиперидины | |
| MX2016006087A (es) | Formulaciones de desintegracion rapida y metodos de uso. | |
| CY1122094T1 (el) | Φαρμακευτικη συνθεση που περιεχει πολυμερες δεσμευσης φωσφορικων | |
| EA201591150A1 (ru) | Твердая единая форма с высоким содержанием фексофенадина и способ ее получения | |
| EA201190313A1 (ru) | Замещенные пиперидины | |
| TR201902755T4 (tr) | Depolama kararliliğina sahi̇p li̇yofi̇li̇ze tri̇pepti̇t formülasyonlari. | |
| MX2018004696A (es) | Analogos de epotilona, metodos de sintesis, metodos de tratamiento y conjugados con farmacos de los mismos. | |
| EA201500446A1 (ru) | Фармацевтическая композиция для снижения уровня n-оксида триметиламина |